Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-24 @ 4:59 PM
NCT ID:
NCT06570850
Eligibility Criteria:
Inclusion Criteria:
* ≥ 20 years old patients who have CRAB infections (pneumonia, urinary tract infection, skin and soft tissue infection, bloodstream infection)
* Able to provide informed consent or having a legal proxy who can provide informed consent in case the subject is unable to provide consent on his own
Exclusion Criteria:
* Minimum inhibitory concentration (MIC) of colistin \> 2 mg/L
* Complicated infection with inadequate source controlled
* Intracranial infection
* Infective endocarditis
* Intraabdominal infection
* Bone and joint infection
* Allergic to or have contraindication(s) to any treatment regimen in the study
* Polymicrobial infection with Carbapenem-resistant Psuedomonas aeruginosa, Carbapenem-resistant Enterobacterales (CRE), Vancomycin-resistant Enterococcus (VRE)
* Pregnancy
* Previous treatment with colistin or fosfomycin more than 96 hours
* Life expectancy of 24 hour or less
* Refusal to participate in the study
* Hospice treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT06570850
Study Brief:
Protocol Section:
NCT06570850